Update date
31 Dec 2025
Shareable Research Card
Keenova Therapeutics plc Return On Invested Capital
This metric view shows Keenova Therapeutics plc return on invested capital history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q4 2025
- Latest reported value
- -12%
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2025
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q4 2025.
- Latest reported value on this page: -12%.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Return On Invested Capital
Latest reported return on invested capital: -12%. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 27 Apr 2026.
Benchmark Context
How Return On Invested Capital compares with peers
Keenova Therapeutics plc is outside the visible top 120 companies for return on invested capital in the current sample.
Compared with
Compared with 120 companies reporting return on invested capital in %. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about -0.7x the current sample midpoint. Return On Invested Capital is down about 168% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2011 to 03 Apr 2026.
- Nearby companies in this sample: AMARIN CORP PLC\UK and USBC, Inc..
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Keenova Therapeutics plc: Return On Invested Capital
Latest period: Q4 2025. Period end: 31 Dec 2025. Units: %. Frequency: quarterly and annual.
Return on invested capital measures how efficiently a company generates operating profit from capital invested in the business. Calculated as net income over shareholder equity plus long-term debt.
Metric Snapshot
- Latest value
- -12%
- Coverage range
- 28 Mar 2014 - 31 Dec 2025
- Fact rows
- 50
What This Metric Tells You
- Shows the reported level of return on invested capital over 28 Mar 2014 - 31 Dec 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 50 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Return On Invested Capital levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | AMARIN CORP PLC\UK (amrn) | 543% | Quarter - 31 Mar 2012 | Open AMARIN CORP PLC\UK Return On Invested Capital |
| 2 | USBC, Inc. (usbc) | 393% | Year - 30 Sep 2019 | Open USBC, Inc. Return On Invested Capital |
| 3 | CPI AEROSTRUCTURES INC (cvu) | 297% | Quarter - 30 Jun 2023 | Open CPI AEROSTRUCTURES INC Return On Invested Capital |
| 4 | Worksport Ltd (wksp) | 214% | Quarter - 30 Sep 2020 | Open Worksport Ltd Return On Invested Capital |
| 5 | HealthLynked Corp (hlyk) | 212% | Year - 31 Dec 2018 | Open HealthLynked Corp Return On Invested Capital |
| 6 | TEAM INC (tisi) | 153% | Quarter - 31 Mar 2023 | Open TEAM INC Return On Invested Capital |
Metric Details
- Metric
- Return On Invested Capital (ROIC)
- Taxonomy
- ratio
- Units tracked
- %
- Frequency coverage
- quarterly and annual
- History range
- 28 Mar 2014 - 31 Dec 2025
- Facts on this page
- 50
- Description
- Return on invested capital measures how efficiently a company generates operating profit from capital invested in the business. Calculated as net income over shareholder equity plus long-term debt.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Return On Invested Capital, Quarterly (%)
Return On Invested Capital, YoY Quarterly Change (%)
Return On Invested Capital, Annual (%)
Return On Invested Capital, YoY Annual Change (%)
Keenova Therapeutics plc Quarterly Return On Invested Capital (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -12% | -29% | -168% | 27 Sep 2025 | 31 Dec 2025 |
| Q3 2025 | 8.2% | +14% | 28 Jun 2025 | 26 Sep 2025 | |
| Q2 2025 | 22% | +122% | 29 Mar 2025 | 27 Jun 2025 | |
| Q1 2025 | 19% | +191% | 28 Dec 2024 | 28 Mar 2025 | |
| Q4 2024 | 17% | +54% | 28 Sep 2024 | 27 Dec 2024 | |
| Q3 2024 | -6.1% | +130% | +95% | 29 Jun 2024 | 27 Sep 2024 |
| Q2 2024 | -101% | -55% | -123% | 30 Mar 2024 | 28 Jun 2024 |
| Q1 2024 | -171% | -149% | -685% | 30 Dec 2023 | 29 Mar 2024 |
| Q4 2023 | -36% | 15 Nov 2023 | 29 Dec 2023 | ||
| Q3 2023 | -136% | 01 Jul 2023 | 29 Sep 2023 | ||
| Q2 2023 | -45% | 01 Apr 2023 | 30 Jun 2023 | ||
| Q1 2023 | -22% | 31 Dec 2022 | 31 Mar 2023 | ||
| Q4 2020 | -25% | -13% | -99% | 26 Sep 2020 | 25 Dec 2020 |
| Q3 2020 | -38% | +4.3% | +10% | 27 Jun 2020 | 25 Sep 2020 |
| Q2 2020 | -31% | +4.8% | +13% | 28 Mar 2020 | 26 Jun 2020 |
| Q1 2020 | -16% | +15% | +48% | 28 Dec 2019 | 27 Mar 2020 |
| Q4 2019 | -13% | +18% | +58% | 28 Sep 2019 | 27 Dec 2019 |
| Q3 2019 | -42% | -55% | -415% | 29 Jun 2019 | 27 Sep 2019 |
| Q2 2019 | -36% | -49% | -364% | 30 Mar 2019 | 28 Jun 2019 |
| Q1 2019 | -32% | -46% | -316% | 29 Dec 2018 | 29 Mar 2019 |
| Q4 2018 | -30% | -49% | -259% | 29 Sep 2018 | 28 Dec 2018 |
| Q3 2018 | 13% | +9.9% | +283% | 30 Jun 2018 | 28 Sep 2018 |
| Q2 2018 | 14% | +9.6% | +245% | 31 Mar 2018 | 29 Jun 2018 |
| Q1 2018 | 15% | +9.6% | +189% | 30 Dec 2017 | 30 Mar 2018 |
| Q4 2017 | 19% | +17% | +666% | 30 Sep 2017 | 29 Dec 2017 |
| Q3 2017 | 3.5% | -2.2% | -38% | 01 Jul 2017 | 29 Sep 2017 |
| Q2 2017 | 3.9% | -1.3% | -25% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | 5.1% | +1% | +25% | 31 Dec 2016 | 31 Mar 2017 |
| Q4 2016 | 2.5% | -1.6% | -39% | 01 Oct 2016 | 30 Dec 2016 |
| Q3 2016 | 5.6% | +2.4% | +76% | 25 Jun 2016 | 30 Sep 2016 |
| Q2 2016 | 5.2% | +6.3% | 26 Mar 2016 | 24 Jun 2016 | |
| Q1 2016 | 4.1% | +6.5% | 26 Dec 2015 | 25 Mar 2016 | |
| Q4 2015 | 4.1% | +8.5% | 26 Sep 2015 | 25 Dec 2015 | |
| Q3 2015 | 3.2% | +10% | 27 Jun 2015 | 25 Sep 2015 | |
| Q2 2015 | -1.1% | -3.4% | -147% | 28 Mar 2015 | 26 Jun 2015 |
| Q1 2015 | -2.4% | -4.9% | -197% | 27 Dec 2014 | 27 Mar 2015 |
| Q4 2014 | -4.4% | 27 Sep 2014 | 26 Dec 2014 | ||
| Q3 2014 | -7% | 28 Jun 2014 | 26 Sep 2014 | ||
| Q2 2014 | 2.3% | 29 Mar 2014 | 27 Jun 2014 | ||
| Q1 2014 | 2.5% | 28 Dec 2013 | 28 Mar 2014 |
Keenova Therapeutics plc Annual Return On Invested Capital (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -12% | -29% | -168% | 28 Dec 2024 | 31 Dec 2025 |
| 2024 | 17% | +106% | 30 Dec 2023 | 27 Dec 2024 | |
| 2023 | -88% | 31 Dec 2022 | 29 Dec 2023 | ||
| 2020 | -25% | -13% | -99% | 28 Dec 2019 | 25 Dec 2020 |
| 2019 | -13% | +18% | +58% | 29 Dec 2018 | 27 Dec 2019 |
| 2018 | -30% | -49% | -259% | 30 Dec 2017 | 28 Dec 2018 |
| 2017 | 19% | +13% | +238% | 31 Dec 2016 | 29 Dec 2017 |
| 2016 | 5.6% | +2.4% | +76% | 26 Sep 2015 | 30 Sep 2016 |
| 2015 | 3.2% | +10% | 27 Sep 2014 | 25 Sep 2015 | |
| 2014 | -7% | 28 Sep 2013 | 26 Sep 2014 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.